Transcranial Direct Current Stimulation for Post-stroke Fatigue
Part of paid clinical trials in New York, New York.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT05816603
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Fatigue
- Stroke Rehabilitaion
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Real Soterix Mini-CT tDCS stimulator — DEVICEReal transcranial electrical stimulation at 2mA intensity will be delivered to the left dorsolateral prefrontal cortex, 20 minutes/day, 14-day duration.
- Sham Soterix Mini-CT tDCS stimulator — DEVICESham stimulation to the left dorsolateral prefrontal cortex, 20 minutes/day, 14-day duration. The device will ramp up and ramp down current delivery from 0 mA -2 mA - 0 mA over 30 seconds at the start of the 20-minute protocol with no active stimulation until the end of the 20 minutes, at which time the 30-second ramp up/ramp down will be repeated.
Study Details
The investigators hypothesize that delivery of anodal tDCS to the left frontal head region will reduce fatigue severity following stroke.
Key Dates
- Start date
- May 23, 2023
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Real tDCS stimulationSubjects randomized to receive real/active electrical stimulation.
- Sham Comparator: Sham tDCS stimulationSubjects randomized to receive sham/non-activating electrical stimulation.
Primary Outcome Measure
Mean change from baseline Fatigue Severity Scale - 7 (FSS-7) [ Time Frame: Screening (-1 to -14 days), Baseline (Day 1), During-treatment (Day 7-9), Post-Treatment (Day 14-21), 1 Month Post-Treatment (Day 45-52)) ]
Central Contacts
- Zhiyan Yang, M.A.(212) 746-1509
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106 | New York | New York | 10065 | Joan Stilling, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Related Studies
- Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of CancerPHASE2 · Recruiting · University of Rochester · Rochester, New York
- Eccentric Exercise and Fatigue in Multiple SclerosisRecruiting · Hunter College of City University of New York · New York, New York
- Patient-Centered Assessment of Symptoms and OutcomesRecruiting · National Center for Complementary and Integrative Health (NCCIH) · Bethesda, Maryland
- Behavioral and Neural Representations of Subjective Effort CostRecruiting · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Baltimore, Maryland